{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:10:08Z","timestamp":1792159808180,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.chest.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T13:50:46Z","timestamp":1750168246000},"page":"1120-1130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Translating the Mechanisms of Hypoxia to Long-Term Oxygen Prescription in COPD"],"prefix":"10.1016","volume":"168","author":[{"given":"Yves","family":"Lacasse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maltais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial","volume":"93","year":"1980","journal-title":"Ann Intern Med"},{"issue":"8222","key":"10.1016\/j.chest.2025.06.003_bib2","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"1","year":"1981","journal-title":"Lancet"},{"issue":"6 pt 2","key":"10.1016\/j.chest.2025.06.003_bib3","first-page":"35","article-title":"Indications for oxygen therapy in chronic obstructive pulmonary disease","volume":"110","author":"Mithoefer","year":"1974","journal-title":"Am Rev Respir Dis"},{"issue":"4 suppl","key":"10.1016\/j.chest.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1016\/0197-2456(87)90015-8","article-title":"Recruitment experience in the Nocturnal Oxygen Therapy Trial","volume":"8","author":"Williams","year":"1987","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.chest.2025.06.003_bib6","series-title":"Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics","first-page":"27","article-title":"From the atmosphere to the mitochondrion: the oxygen cascade","author":"Biro","year":"2013"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/arrd.1983.127.4.397","article-title":"Selection criteria for long-term oxygen","volume":"127","author":"Petty","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1164\/rccm.200507-1161WS","article-title":"Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report","volume":"174","author":"Croxton","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1742-1241.2011.02833.x","article-title":"Long-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatment","volume":"66","author":"Gulbas","year":"2012","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.chest.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S2213-2600(22)00179-5","article-title":"Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"10","author":"Lacasse","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1183\/09031936.00137106","article-title":"Haemoglobin level and its clinical impact in a cohort of patients with COPD","volume":"29","author":"Cote","year":"2007","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.08-0117","article-title":"Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial","volume":"134","author":"Drummond","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.chest.2025.06.003_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.rmed.2011.02.015","article-title":"Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study","volume":"105","author":"Kim","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2025.06.003_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/COPD.S148673","article-title":"Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward","volume":"13","author":"Ekstrom","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2014similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Molecules and Cells"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI31750","article-title":"HIF-1 and HIF-2: working alone or together in hypoxia?","volume":"117","author":"Ratcliffe","year":"2007","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.chest.2025.06.003_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/febs.13572","article-title":"HIF3alpha: the little we know","volume":"283","author":"Ravenna","year":"2016","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1073\/pnas.022634199","article-title":"Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1 alpha","volume":"99","author":"Kline","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev"},{"issue":"12","key":"10.1016\/j.chest.2025.06.003_bib22","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1002\/jcp.26805","article-title":"The role of hypoxia-inducible factor-2 alpha in angiogenesis","volume":"233","author":"Befani","year":"2018","journal-title":"J Cell Physiol"},{"issue":"9","key":"10.1016\/j.chest.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","article-title":"The effect of HIF on metabolism and immunity","volume":"18","author":"Taylor","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.chest.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fphys.2019.01534","article-title":"The many facets of erythropoietin physiologic and metabolic response","volume":"10","author":"Suresh","year":"2019","journal-title":"Front Physiol"},{"issue":"33","key":"10.1016\/j.chest.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"16177","DOI":"10.1073\/pnas.1909002116","article-title":"The overlooked significance of plasma volume for successful adaptation to high altitude in Sherpa and Andean natives","volume":"116","author":"Stembridge","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/ham.2023.0111","article-title":"Adaptation to living at high altitude in patients with COPD. Comparative study of exercise capacity and ventilatory variables between patients residing at high and low altitudes in the Andes","volume":"25","author":"Gonzalez-Garcia","year":"2024","journal-title":"High Alt Med Biol"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCP.0000000000001092","article-title":"Pulmonary vascular diseases at high altitude\u2014is it safe to live in the mountains?","volume":"30","author":"Titz","year":"2024","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/1527029041352162","article-title":"Sleep at high altitude","volume":"5","author":"Weil","year":"2004","journal-title":"High Alt Med Biol"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib29","doi-asserted-by":"crossref","first-page":"R474","DOI":"10.1152\/ajpregu.00021.2023","article-title":"The effect of hypoxemia on muscle sympathetic nerve activity and cardiovascular function: a systematic review and meta-analysis","volume":"325","author":"Tymko","year":"2023","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"pt 7","key":"10.1016\/j.chest.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1242\/jeb.112862","article-title":"Divergent physiological responses in laboratory rats and mice raised at high altitude","volume":"218","author":"Jochmans-Lemoine","year":"2015","journal-title":"J Exp Biol"},{"issue":"22","key":"10.1016\/j.chest.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.1120523109","article-title":"Regulatory changes contribute to the adaptive enhancement of thermogenic capacity in high-altitude deer mice","volume":"109","author":"Cheviron","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.chest.2025.06.003_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.chest.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-kappaB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20080476","article-title":"Regulation of hypoxia-inducible factor-1alpha by NF-kappaB","volume":"412","author":"van Uden","year":"2008","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/cyto.1999.0533","article-title":"High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein","volume":"12","author":"Hartmann","year":"2000","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib36","first-page":"1582","article-title":"Hypoxia stimulates cytokine production by villous explants from the human placenta","volume":"82","author":"Benyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.chest.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"7211","DOI":"10.4049\/jimmunol.177.10.7211","article-title":"A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells","volume":"177","author":"Kim","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"00301","DOI":"10.1183\/23120541.00301-2022","article-title":"Biomarker-based clustering of patients with chronic obstructive pulmonary disease","volume":"9","author":"Vanfleteren","year":"2023","journal-title":"ERJ Open Res"},{"issue":"7","key":"10.1016\/j.chest.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2025.06.003_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158843","article-title":"A systematic review of diagnostic biomarkers of COPD exacerbation","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"4 pt 1","key":"10.1016\/j.chest.2025.06.003_bib41","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1164\/ajrccm.161.4.9903022","article-title":"The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease","volume":"161","author":"Takabatake","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2010.154484","article-title":"Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes","volume":"66","author":"Garcia-Aymerich","year":"2011","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.chest.2025.06.003_bib43","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease","volume":"185","author":"Celli","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1513\/pats.200708-124ET","article-title":"Oxygen therapy in chronic obstructive pulmonary disease","volume":"5","author":"Kim","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","article-title":"Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial","volume":"198","author":"Kunisaki","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00391-2017","article-title":"What is precision medicine?","volume":"50","author":"Konig","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152618","article-title":"Continuing to Confront COPD International Patient Survey: economic impact of COPD in 12 countries","volume":"11","author":"Foo","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12890-022-01891-6","article-title":"Experiences in elderly people with chronic obstructive pulmonary disease in relation to the use of long-term home oxygen therapy: a qualitative study about feelings attributed to therapy","volume":"22","author":"Bueno","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.chest.2025.06.003_bib49","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.2147\/COPD.S228465","article-title":"Physical activity in patients with chronic obstructive pulmonary disease on long-term oxygen therapy: a cross-sectional study","volume":"14","author":"Paneroni","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/23120541.00068-2021","article-title":"Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease","volume":"7","author":"Balasubramanian","year":"2021","journal-title":"ERJ Open Res"},{"issue":"7","key":"10.1016\/j.chest.2025.06.003_bib52","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4187\/respcare.01961","article-title":"Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure","volume":"58","author":"Kollert","year":"2013","journal-title":"Respir. Care"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1378\/chest.128.3.1201","article-title":"Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy","volume":"128","author":"Chambellan","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.chest.2025.06.003_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/oxfordjournals.qjmed.a066936","article-title":"Polycythemia in emphysema","volume":"118","author":"Shaw","year":"1961","journal-title":"Q J Med"},{"key":"10.1016\/j.chest.2025.06.003_bib55","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.1503\/cmaj.191587","article-title":"Investigation and management of erythrocytosis","volume":"192","author":"Mithoowani","year":"2020","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12890-021-01585-5","article-title":"Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2025.06.003_bib57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/rmed.2001.1070","article-title":"Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease","volume":"95","author":"Tassiopoulos","year":"2001","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2141.1989.tb07657.x","article-title":"Circadian rhythm of erythropoietin in human serum","volume":"72","author":"Wide","year":"1989","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.chest.2025.06.003_bib59","first-page":"183","article-title":"Diurnal rhythm of serum erythropoietin circulating levels in chronic obstructive pulmonary disease","volume":"39","author":"Casale","year":"1997","journal-title":"Panminerva Med"},{"key":"10.1016\/j.chest.2025.06.003_bib60","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/hrt.2005.071233","article-title":"Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine","volume":"92","author":"Weber","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.chest.2025.06.003_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4330\/wjc.v6.i1.4","article-title":"Physiology of natriuretic peptides: the volume overload hypothesis revisited","volume":"6","author":"Arjamaa","year":"2014","journal-title":"World J Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2019.01.007","article-title":"Endothelin-1 levels and cardiovascular events","volume":"30","author":"Jankowich","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00005-014-0310-1","article-title":"The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis","volume":"63","author":"Kowalczyk","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"10.1016\/j.chest.2025.06.003_bib65","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/resp.14439","article-title":"Variability of fractional exhaled nitric oxide is associated with the risk and aetiology of COPD exacerbations","volume":"28","author":"Schumann","year":"2023","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.chest.2025.06.003_bib66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12931-019-1133-8","article-title":"Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD","volume":"20","author":"Csoma","year":"2019","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/ajrccm.152.2.7543345","article-title":"Acute and chronic effects of cigarette smoking on exhaled nitric oxide","volume":"152","author":"Kharitonov","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2025.06.003_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells11101720","article-title":"Angiogenesis, lymphangiogenesis, and inflammation in chronic obstructive pulmonary disease (COPD): few certainties and many outstanding questions","volume":"11","author":"Poto","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.chest.2025.06.003_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030131","article-title":"Albuminuria: an underappreciated risk factor for cardiovascular disease","volume":"13","author":"Barzilay","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.chest.2025.06.003_bib70","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1183\/09031936.00012408","article-title":"Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD","volume":"32","author":"Mannino","year":"2008","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.chest.2025.06.003_bib71","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1604344","article-title":"A randomized trial of long-term oxygen for COPD with moderate desaturation","volume":"375","author":"Albert","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2025.06.003_bib72","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00109-018-1708-8","article-title":"Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease","volume":"96","author":"Seo","year":"2018","journal-title":"J Mol Med"},{"key":"10.1016\/j.chest.2025.06.003_bib73","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/COPD.S204391","article-title":"Patient registries for home oxygen research and evaluation","volume":"14","author":"Lacasse","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922500697X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922500697X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:31:03Z","timestamp":1787257863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922500697X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S001236922500697X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2025.06.003","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translating the Mechanisms of Hypoxia to Long-Term Oxygen Prescription in COPD","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}